Haemonetics Corp (HAE)
24.82 x 1 N/A x N/A
Post-market by (Cboe BZX)
62.51 +0.59 (+0.95%) 04/25/25 [NYSE]
24.82 x 1 N/A x N/A
Post-market 62.51 unch (unch) 16:01 ET
for Fri, Apr 25th, 2025
Results
download Want to compare other data? Select Fields| Symbol | HAE | ICUI | NVST | ||
| Company | Haemonetics Corp | I C U Medical Inc | Envista Holdings Corp | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 61.81 | 138.09 | 15.92 | ||
| High | 62.56 | 138.09 | 16.26 | ||
| Low | 61.24 | 134.79 | 15.62 | ||
| Last | 62.51 | 135.66 | 15.94 | ||
| Change | +0.59 | -1.50 | -0.04 | ||
| % Change | +0.95% | -1.09% | -0.25% | ||
| Volume | 446,400 | 164,500 | 2,273,400 | ||
| 20-Day Average Volume | 732,445 | 344,520 | 3,288,460 | ||
| Previous Close | 61.92 | 137.16 | 15.98 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 60.25 | 138.85 | 15.83 | ||
| 20-Day Raw Stochastic | 80.83% | 36.56% | 45.50% | ||
| 20-Day Relative Strength | 50.36% | 44.59% | 44.94% | ||
| Weighted Alpha | -33.68 | +19.47 | -24.38 | ||
| Today's Opinion | 88% Sell | 100% Sell | 72% Sell | ||
| Previous Opinion | 88% Sell | 100% Sell | 72% Sell | ||
| Last Month's Opinion | 100% Sell | 56% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.34% since 04/17/25 | -2.17% since 04/17/25 | +5.01% since 04/17/25 | ||
| Low | 55.44 on 04/21/25 | 126.00 on 04/22/25 | 14.72 on 04/21/25 | ||
| High | 62.56 on 04/25/25 | 139.12 on 04/22/25 | 16.82 on 04/23/25 | ||
| 1-Month | |||||
| %Chg | -1.33% since 03/25/25 | -9.49% since 03/25/25 | -8.65% since 03/25/25 | ||
| Low | 55.30 on 04/09/25 | 126.00 on 04/22/25 | 14.22 on 04/09/25 | ||
| High | 64.66 on 03/27/25 | 152.42 on 04/09/25 | 18.04 on 03/27/25 | ||
| 3-Month | |||||
| %Chg | -11.73% since 01/24/25 | -21.27% since 01/24/25 | -25.69% since 01/24/25 | ||
| Low | 55.30 on 04/09/25 | 126.00 on 04/22/25 | 14.22 on 04/09/25 | ||
| High | 71.94 on 01/28/25 | 175.51 on 01/27/25 | 22.68 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | -17.27% since 10/25/24 | -22.73% since 10/25/24 | -15.62% since 10/25/24 | ||
| Low | 55.30 on 04/09/25 | 126.00 on 04/22/25 | 14.22 on 04/09/25 | ||
| High | 94.99 on 11/12/24 | 196.26 on 11/13/24 | 23.00 on 10/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,058,428 | 3,428,665 | 2,665,470 | ||
| Shares Outstanding, K | 50,237 | 24,610 | 172,188 | ||
| Annual Sales | 1,309,060,000 | 2,382,050,000 | 2,510,600,000 | ||
| Annual Net Income | 117,560,000 | -117,690,000 | -1,118,600,000 | ||
| Last Quarter Sales | 348,540,000 | 629,800,000 | 652,900,000 | ||
| Last Quarter Net Income | 37,490,000 | -23,830,000 | 1,200,000 | ||
| 60-Month Beta | 0.41 | 0.86 | 1.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.19 on 02/06/25 | 2.11 on 02/27/25 | 0.24 on 02/05/25 | ||
| Latest Earnings Date | 05/08/25 | 05/08/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | 1.500 on 03/18/02 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 14.78 | 28.44 | 21.84 | ||